- Home
- LOCO vs ABSI Comparison
LOCO vs ABSI Comparison
Compare LOCO & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOCO | ABSI |
|---|---|---|
| Founded | 1980 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 456.5M | 997.8M |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LOCO | ABSI |
|---|---|---|
| Price | $14.43 | $7.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $14.17 | $6.96 |
| AVG Volume (30 Days) | 190.7K | ★ 2.6M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 4.65 | ★ 10.64 |
| EPS | ★ 0.70 | N/A |
| Revenue | ★ $401,701,000.00 | $4,534,000.00 |
| Revenue This Year | $3.60 | $215.96 |
| Revenue Next Year | $3.98 | $319.10 |
| P/E Ratio | $20.73 | ★ N/A |
| Revenue Growth | ★ 5.68 | N/A |
| 52 Week Low | $8.99 | $2.24 |
| 52 Week High | $17.40 | $12.06 |
Technical Indicators
Market Signals| Indicator | LOCO | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 36.88 | 39.27 |
| Support Level | $13.52 | $6.69 |
| Resistance Level | $15.68 | $10.03 |
| Average True Range (ATR) | 0.37 | 0.49 |
| MACD | -0.03 | -0.13 |
| Stochastic Oscillator | 6.59 | 6.96 |
Price Performance
Historical ComparisonAbout LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. It specializes in fire-grilling citrus-marinated chicken and operates in the limited service restaurant market segment. Its offerings include Mexican-inspired menu items, including burritos, tostadas, bowls, salads, and bone-in chicken meals in various portion sizes. It also offers citrus-marinated fire-grilled chicken, along with a range of salsas and dressings that allow customers to customize their meals. The company operates in one operating segment. The majority of the company's revenue is derived from company-operated restaurant revenue.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.